跳至主要内容
临床试验/NCT05830487
NCT05830487Enrolling By Invitation不适用

Effect of Dietary Intervention on Serum Advanced Glycation End Products and Metabolic Profile in Polycystic Ovary Syndrome Patients

Hacettepe University2 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2021年11月30日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
24
试验地点
2
主要终点
Total antioxidant/oxidant capacity

研究概览

简要总结

Recently, the negative effects of advanced glycation end products on the pathophysiology of some diseases have attracted attention. This study was planned to evaluate the effect of dietary intervention and weight loss on serum advanced glycation and disease pathogenesis in patients with polycystic ovary syndrome.

详细描述

The significantly increased consumption of processed foods in recent years has also increased the amount of sugar and fat in the diet. These changes in dietary habits also increase exposure to advanced glycation end products. Advanced glycation end products (AGEs) are the products occurred as a result of the Maillard reaction by the combination of the carbonyl group of carbohydrates and the free amino groups of amino acids. Advance glycation end products causes irreversible cross-linking of proteins, resulting in loss of protein structure and function. Advanced glycation end products formation is a slow process in normal conditions, but chronic diseases such as diabetes, insulin resistance, aging, oxidative stress and PCOS accelerate the occurrence of endogenous AGEs.

Polycystic ovary syndrome (PCOS) is an endocrine disorder that is characterized by hyperandrogenism, oligo/anovulation and polycystic ovaries and it affects up to 25% of reproductive-aged women. Women with PCOS have been shown to have an increase in the levels of AGEs in the bloodstream and the expression of proinflammatory receptors of AGEs in the ovaries, such as RAGE. In addition, the levels of protective anti-inflammatory receptors called soluble receptors for advanced glycation end products (sRAGE) were found to be low in women with PCOS. Patient with PCOS in particular have high levels of serum AGEs, regardless of their body weight or the presence of insulin resistance.

In this project, aimed to investigate effect of a diet with reduced energy and fat content and a low AGE diet with reduced energy and fat content for 12 weeks in overweight and obese individuals with polycystic ovary syndrome.

Body composition, anthropometric measurements, serum AGE levels, serum antioxidant capacity, inflammation, cardio metabolic profile, hormonal profile, and also Anti-Mullerian Hormone (AMH) values will be examined in individuals and the results will be evaluated by comparing diet groups. Volunteers participating in the study will apply one of two different dietary treatments to be determined by stratified randomization method for 12 weeks. The smallest sample size was calculated as a total of 24 patients, 12 patients in each intervention group, taking into account the change in serum AGE value at 80% power and 95% confidence intervals.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
19 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Being diagnosed with PCOS Being between the ages of 19-35 Having a body mass index of more than 25 kg/m2 Volunteering to work

排除标准

  • Presence of chronic disease (Diabetes, Hypertension, Atherosclerotic heart diseases, gastrointestinal system diseases..)
  • Being in pregnancy-lactation or menopause period
  • Using oral contraceptive medication
  • Using vitamin-mineral support
  • Receiving a special dietary treatment
  • To have applied a weight loss diet in the last 3 months

结局指标

主要结局

Total antioxidant/oxidant capacity

时间窗: 12 weeks

The comparison total antioxidant/oxidant capacity levels of 24 patients before and after dietary intervention

Serum advanced glycation end products levels

时间窗: 12 weeks

The comparison of serum advanced glycation end products levels of 24 patients before and after dietary intervention

Cardio metabolic profile

时间窗: 12 weeks

The comparison of fasting insulin (mg/dL), fasting blood sugar (mg/dL), lipid parameters (triglyceride (mg/dL), LDL-C (mg/dL), HDL-C (mg/dL), total cholesterol (mg/dL)) values of 24 patients at baseline and week 12.

İnflammation

时间窗: 12 weeks

The comparison tnf-a and hs-CRP levels of 24 patients before and after dietary intervention

Hormonal Profile

时间窗: 12 weeks

From hormonal indicators total testosterone (ng/mL), sex hormone-binding globulin ng/mL) , Anti mullerian hormone (ng/mL) values of 24 patients at baseline and week 12 will be compared.

次要结局

  • Body composition(12 weeks)
  • Body Mass İndex(12 weeks)
  • Circumference measurements(12 weeks)
  • Body weight(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Merve Özdemir

Research Assistant

Hacettepe University

研究点 (2)

Loading locations...

相似试验

Advanced Glycation End Products and Dietary... | 临床试验